KIROMIC BIOPHARMA INC (KRBP)
US4976342042 - Common Stock
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
Live and Archived Fireside Chat Available at VirtualInvestorConferences.com
Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer
Kiromic BioPharma Reports Favorable Early Safety and Tolerability Data from First Patient Enrolled in the Phase 1 Deltacel-01 Clinical Trial
Kiromic BioPharma Announces First Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung Cancer
Kiromic BioPharma Announces Uplisting to OTCQB Market
Kiromic BioPharma Announces Deltacel™ Phase 1 Clinical Trial Enters Patient Recruitment Phase at Beverly Hills Cancer Center
Kiromic BioPharma and Beverly Hills Cancer Center Enter Clinical Trial Agreement
Kiromic BioPharma to list on OTC Pink Sheets after Nasdaq trading suspension (NASDAQ:KRBP)
Kiromic BioPharma (KRBP) Wednesday said it received a formal notice that its common stock was suspended from trading on the Nasdaq Capital Market.Subsequently, the company added that...
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14
Kiromic BioPharma Welcomes Two New Directors to its Board
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!